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Although myelodysplastic syndromes have a clear definition in theory, the morphologic dys-
plasia associated with ineffective hematopoiesis may be subtle and difficult to recognize and
can  commonly be mimicked by systemic conditions, such as infections, autoimmune disor-
ders,  nutritional deficiencies, toxic factors and non-hematological malignancies. However,
myelodysplastic syndromes may truly coexist with other systemic diseases, which can be
masked when the patient’s symptoms are attributed exclusively to myelodysplastic syn-
dromes without further investigation. To better illustrate this, we  herein describe two cases
associated with synchronous gastric cancers.Hematologic neoplasms
Secondary neoplasms
Primary neoplasms
©  2014 Associac¸ão Brasileira de Hematologia, Hemoterapia e Terapia Celular. Published
by Elsevier Editora Ltda. All rights reserved.Introduction
The myelodysplastic syndromes (MDS) are clonal hematopoi-
etic stem cell disorders characterized by dysplasia of at least
one of the myeloid cell lines, increased apoptosis and inef-
fective hematopoiesis. They comprise a heterogeneous group
of diseases varying from indolent cases, characterized pre-
dominantly by cytopenias, to aggressive disease showing high
blast counts and a significant propensity to evolve into acute
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reserved.myeloid leukemia.1 Thus, medical centers utilize the World
Health Organization (WHO) 2008 criteria and the International
Prognosis Scoring System (IPSS) to classify and predict prog-
nosis in these patients.
Although MDS have a clear definition in theory, the mor-
phologic dysplasia associated with ineffective hematopoiesis
may be subtle and difficult to recognize,2 and can commonlypinas (UNICAMP), Rua Carlos Chagas, 480, 13083-878 Campinas,
be mimicked by other systemic conditions, such as infec-
tions, autoimmune disorders, nutritional deficiencies, toxic
factors and non-hematological malignancies.1 However, MDS
 e Terapia Celular. Published by Elsevier Editora Ltda. All rights
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Figure 1 – Bone marrow histology. Moderate
hypercellularity and mild maturation arrest of the
granulocytic compartment, predominating in the
erythroblast compartment. Megakaryocytes are increased
in number and are hypolobulated (hematoxylin and eosin:rev bras hematol hemot
ay truly coexist with other systemic diseases, which can be
asked if the patient’s symptoms are attributed exclusively
o MDS  without further investigation. To better illustrate this,
e  report on two cases of MDS  associated with synchronous
astric cancers. The first patient is a young lady who pre-
ented with moderate anemia and constitutional symptoms.
he second case is a 67-year-old man  with pancytopenia and
atigue.
ase  1
ur first patient, a 36-year-old woman with a previous his-
ory of diabetes mellitus and ischemic cardiomyopathy had
omplaints of persistent anemia, fatigue and weight loss
17 pounds in six months). She was 19 weeks pregnant
nd had no other significant past medical, family or
xposure history. The results of her physical examination
ere unremarkable. She had never required red blood cell
ransfusions. Her complete blood counts showed the fol-
owing: hemoglobin = 6.0 mg/dL, mean corpuscular volume
MCV) = 96.3 fL, platelet count = 158 × 109/L, and absolute neu-
rophil count = 2.9 × 109/L. Iron studies were normal and
utritional deficiencies were ruled out. She had no signs of
nfectious diseases and serology for hepatitis B and C, human
mmunodeficiency virus (HIV) and cytomegalovirus (CMV)
ere negative. A bone marrow (BM) biopsy was performed
hich showed hypercellularity (95–100%) with no atypias or
eticulin fibrosis. BM cytology showed 4.4% of blasts with
o significant dysplastic changes in any hematopoietic lin-
ages, normal iron stores and no ring sideroblasts. Cytogenetic
nalysis was normal (46,XX). Flow cytometry detected three
mmunophenotypic abnormalities. At that time, the criteria
as not yet sufficient to establish a definitive hematologic
iagnosis. The patient received two units of packed red cells
nd her blood counts remained stable during the rest of the
regnancy.
After delivery, the patient evolved with a deterio-
ation of blood counts (hemoglobin = 6.1 mg/dL, platelet
ount = 78 × 109/L, and absolute neutrophil count = 3.3 × 109/L)
nd began to require frequent red blood cell transfusions.
one marrow cytology was again performed and showed 11%
f blasts, with no significant dysplasia and a normal karyo-
ype. A BM biopsy revealed hypolobulated megakaryocytes
Figure 1). The diagnosis of MDS  (WHO 2008 refractory ane-
ia  with excess blasts-2 [RAEB-2] and IPSS Intermediate-2)
as reached.
Subsequently, as the patient complained of further signif-
cant weight loss and constitutional symptoms, a screening
or malignancies was performed: a chest X-ray was nor-
al, but an abdominal computed tomography scan showed
 homogeneous enlargement of the spleen (30 cm), and an
pper gastrointestinal endoscopy showed an advanced ele-
ated lesion in the stomach with a biopsy confirming a gastric
ubular adenocarcinoma with areas showing a diffuse pat-
ern of signet-ring cell carcinoma. She was submitted to total
astrectomy with lymphadenectomy and splenectomy. The
tomach biopsy confirmed a diffuse signet-ring cell carcinoma
ith involved margins and signs of lymphatic and perineural
nvasion, whereas the spleen biopsy showed only hyperplasia.400×).
The patient started chemotherapy with the etoposide, l-
leucovorin and fluorouracil (ELF) regimen for advanced gastric
cancer, but died four months later due to a massive pulmonary
thromboembolism.
Case  2
The second case is a 67-year-old gentleman who  com-
plained of weakness, fatigue and weight loss (31 pounds
in four months). He had been diagnosed with systemic
hypertension, diabetes mellitus and congestive heart failure,
but no other significant past medical, family or expo-
sure history. His physical examination was unremarkable.
His complete blood count revealed: hemoglobin = 6.4 mg/dL,
MCV  = 112.0 fL, platelet count = 28 × 109/L, and absolute neu-
trophil count = 0.7 × 109/L. Screening for nutritional deficien-
cies showed a vitamin B12 level of 190 pg/mL (below reference
range). A BM biopsy showed moderate hypercellularity with
atypical megakaryocytes (Figure 2), no significant dysplas-
tic changes and moderate diffuse reticulin fibrosis. A BM
aspiration revealed dyserythropoiesis, cytoplasmic hypogran-
ularity, no megaloblastic changes, no ring sideroblasts and
9% of blasts, with normal cytogenetics (46,XY). Flow cytom-
etry detected five immunophenotypic abnormalities. Vitamin
B12 was supplemented, but there was no increase in blood
counts. Infectious diseases were ruled out. The diagnosis of
MDS (WHO 2008 RAEB-1 and IPSS Intermediate-1) was reached
and the patient was included in the regular transfusion pro-
gram.
An abdominal and chest computed tomography scan
was performed to investigate the constitutional symptoms
of the patient and his significant weight loss, but no
significant abnormalities were observed. An upper gastroin-
testinal endoscopy showed diffuse atrophic gastritis and a
depressed gastric lesion, with a biopsy showing a gastric
444  rev bras hematol hemoter. 2 0 1 4;3  6(6):442–444
Figure 2 – Bone marrow histology. (A) Intense hypercellularity and maturation arrest of hematopoietic components.
Megakaryocytes are atypical: dwarf and hypolobulated (hematoxylin and eosin: 400×). (B) Silver impregnation shows
r
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2001;74(1):64–9.moderate increase in reticulin fibers (400×).
adenocarcinoma in situ. A therapeutic upper gastrointesti-
nal endoscopy was subsequently carried out, but endoscopic
resection of the lesion was not possible, since the gas-
tric mucosa was friable and hemorrhagic. At that time,
blood counts continued to drop (hemoglobin = transfusion
dependent, platelet count = 6 × 109/L, absolute neutrophil
count = 0.3 × 109/L). The patient was subsequently submitted
to a partial laparoscopic gastric resection, but died eleven days
later due to postoperative fever and severe sepsis.
Discussion  and  conclusions
As the diagnosis of MDS  is based mainly on an assess-
ment of the morphology, the diagnosis can be subjective,
particularly in patients with early low risk disease pre-
senting a normal karyotype. In general, diagnosis is easier in
patients with excess blasts. Since there are many  conditions
that can mimic  MDS,  a clinical assessment with the exclu-
sion of additional systemic conditions, such as nutritional
deficiencies, autoimmune disorders and non-hematological
malignancies is needed.3 There are no studies describing
the incidence of synchronous non-hematological neoplasms
occurring concurrently with MDS,  and so this seems to
be relatively uncommon. However, the presence of symp-
toms which are not frequently associated with MDS, such
as significant constitutional symptoms, excessive weight
loss and localized pain should raise clinical suspicion of
associated malignancies, leading to an extensive investiga-
tion.
Herein we  described two cases of synchronous gastric can-
cer and myelodysplasia in a young and an elderly patient. This
is a rare condition, and there are very few reports describing
this association.4,5 Similarly, in the clinical practice, drops in
blood counts of patients with non-hematological malignan-
cies are very frequently attributed to ‘secondary’ conditions,
such as, for example, chronic disease anemia and immune
thrombocytopenias. It is important to point out the possibil-
ity of coexistence of MDS  with other neoplasms and so bone
marrow studies should always be considered.
5Regarding the simultaneous occurrence of MDS  and non-
hematological neoplasms, we  hypothesize that an initial event
selecting a stem cell clone, together with abnormalities in
immunosurveillance, may manifest with a higher propensity
to cancer. Alternatively, an increased chromosomal instabil-
ity which seems to be associated with immunodeficiencies
might be responsible for the development of cancer.5 Finally,
a decreased function of tumor suppression genes could be
an important final factor that would allow malignant cells to
proliferate.
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